Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail (EPRIDIA)

November 17, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Feasibility of the Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail "La Santé" (Maison d'arrêt Paris La Santé)"

A lot of data show that therapeutic education is beneficial for diabetic patients. In the French jails, there are very few programs of therapeutic education while this population is usually precarious with no access at care sector before the jail.

The purpose of this study is to determinate if the therapeutic education of the diabetic patients is possible in the Paris jail "La Santé".

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The Paris jail "La Santé" welcomes 600 men who stay 5 month on average. Each year, there are between 30 to 40 diabetic patients. In the jail there's a sanitary unit who is a unit of internal medicine of Cochin hospital. This unit includes nurses, pharmacists and medical doctors.

We propose to include in this study all diabetic patients (type 1 and 2) with the realization of a consultation of educational diagnosis, followed by the participation for every patient to 4 educational collective workshops therapeutic (knowledge of the disease, food, physical Activity and care of feet, the therapeutics)

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75014
        • Hopital Cochin
      • Paris, France, 75014
        • Maison d'Arrêt Paris La Santé (MAPLS)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male patient detained in the MAPLS of more than 18 years
  • Patient prisoner in the MAPLS for more than 15 days
  • Patient follow-up for a diabetes of type 1 or type 2
  • Patient informed about the study and not having opposed to this one
  • Patient taken out of the disciplinary district which had previously been included for this motive

Exclusion Criteria:

  • Patient considered incapable by the investigator to follow an ETP program
  • Patient having a bad understanding of the spoken French language
  • Patient whose duration of confinement known about the MAPLS is strictly lower than 1 month in the inclusion during the year 2013/2014
  • Patient prisoner in the district of isolation
  • Patient prisoner in the disciplinary district in the inclusion
  • Patient prohibition to communicate with another prisoner already registered on the session to come

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapeutic Education
Intensive training individual or collective teaching

Realization of a consultation of educational diagnosis, followed by the participation for every patient to 4 educational collective workshops therapeutic:

  • Knowledge of the disease
  • Food
  • Physical Activity and care of feet
  • The therapeutics
Other Names:
  • Intensive training individual and collective teaching

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The feasibility of the application of the action ETP in the MAPLS
Time Frame: 3 months
Rate of participation to at least two therapeutic workshops
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimation of the satisfaction of the prisoners and the nursing after participation of educational therapeutic workshops
Time Frame: 3 months
To fill in an auto-questionnaire by means of the scale of Likert in 5 points
3 months
biomedical parameters: HbA1c and IMC
Time Frame: 3 months
Clinical evolution of the patients
3 months
The number of hours all in all, for all the activities ETP and by categories of tasks
Time Frame: 3 months
To evaluate of the mobilized resources
3 months
The satisfaction of the staffs as for the implementation and the realization of the experiment
Time Frame: 3 months
to evaluate of the mobilized resources
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Benjamin SILBERMANN, MD, PhD, Assistance Publique - Hopitaux de Paris
  • Study Director: Laura HARCOUET, Pharm D, Assistance Publique - Hopitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

June 5, 2014

First Submitted That Met QC Criteria

June 5, 2014

First Posted (Estimated)

June 9, 2014

Study Record Updates

Last Update Posted (Actual)

November 20, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2013-A00704-41

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 or 2 Diabetes

Clinical Trials on Therapeutic Education

Subscribe